Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01867359 · ClinicalTrials.gov registry record

The Genetic Characterization of Dementia

A clinical trial, sponsored by National Institute on Aging (NIA).

Completed
Registry status
87
Enrollment target

NCT01867359 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 87 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01867359 has completed, sponsored by National Institute on Aging (NIA).

COMPLETED
Registry status
87 participants
Enrollment target

Study Summary

Background: \- Researchers are interested in learning more about dementia and its causes. They want to look at the genetic basis of dementia. Identifying genetic aspects of dementia may help provide better tests and treatments for it. It may also show rare gene variants that can cause or alter a person's risks for developing dementia. This study will look at people who have dementia, their family members, and healthy volunteers. Objectives: \- To study genetic influences on dementia. Eligibility: * Individuals who have been diagnosed with dementia. * Family members of individuals who have been diagnosed with dementia. * Healthy volunteers at least 18 years of age. Design: * Participants will be interviewed and answer questions about their medical history. They will also provide general information on the relatives' medical histories. * Participants will provide a blood sample for genetic testing. * Participants will remain on the study for up to 10 years. They will have regular visits to monitor their brain health and function. * Treatment will not be provided as part of this study.

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2003-03-14
Est. Completion 2016-09-20

Sponsor

National Institute on Aging (NIA)

131 total trials

What the Registry Record Tells You About NCT01867359

The ClinicalTrials.gov registry entry for NCT01867359 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01867359 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01867359 about?

NCT01867359 is a clinical study titled "The Genetic Characterization of Dementia". Background: \- Researchers are interested in learning more about dementia and its causes. They want to look at the genetic basis of dementia. Identifying genetic aspects of dementia may help provide better tests and treatments for it. It may also show rare gene variants that can cause or alter a pe...

What is the current status of trial NCT01867359?

This trial is currently completed. The enrollment target is 87 participants. The study started on 2003-03-14. Estimated completion is 2016-09-20.

Who is sponsoring clinical trial NCT01867359?

This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.